Skip to main content

Table 2 In vitro susceptibility results of pneumonia and non-pneumonia-related A. baumannii bacteremia to major drugs

From: Risk factors for bacteremic pneumonia and mortality (28-day mortality) in patients with Acinetobacter baumannii bacteremia

Antibiotic

types

Total (n = 117)

Pneumonia-related bacteremia (n = 45)

Nonpneumonia-

related bacteremia (n = 72)

Χ2

P

Minocycline

Amikacin

Meropenem

Imipenem

Tigecycline

Colistin

62.64%(57/91)

73.91%(17/23)

31.11%(28/90)

41%(48/117)

69.61%(71/102)

96.63%(86/89)

39.02%(16/41)

20%(1/5)

15%(6/40)

20%(9/45)

58.14%(25/43)

97.56%(40/41)

82%(41/50)

88.89%(16/18)

44%(30/72)

54.1%(39/72)

77.96%(46/59)

95.83%(46/48)

17.77

9.63

8.38

13.36

4.62

0.2

0

0.008

0.006

0

0.049

1